Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients.

ABSTRACT:

SUBMITTER: Schuelke MR 

PROVIDER: S-EPMC10514204 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature